lobbying_filings_raw: f7d6f86b-4e75-489c-93eb-b788ce3dc79e

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
f7d6f86b-4e75-489c-93eb-b788ce3dc79e Q3 50796 WINNING STRATEGIES WASHINGTON 157082 KALEO 2017 third_quarter 2017-10-16T14:57:04.083000-04:00 30000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/f7d6f86b-4e75-489c-93eb-b788ce3dc79e/", "filing_uuid": "f7d6f86b-4e75-489c-93eb-b788ce3dc79e", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2017, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/f7d6f86b-4e75-489c-93eb-b788ce3dc79e/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Donna F. Mullins, Managing Partner", "dt_posted": "2017-10-16T14:57:04.083000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "409 7TH STREET, NW", "registrant_address_2": "SUITE 450", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20004", "registrant": {"id": 50796, "url": "https://lda.senate.gov/api/v1/registrants/50796/", "house_registrant_id": 34724, "name": "WINNING STRATEGIES WASHINGTON", "description": "Government relations firm", "address_1": "409 7TH STREET, NW", "address_2": "SUITE 450", "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "CARL CHIDLOW", "contact_telephone": "+1 202-589-0800", "dt_updated": "2026-01-28T09:17:29.205119-05:00"}, "client": {"id": 157082, "url": "https://lda.senate.gov/api/v1/clients/157082/", "client_id": 1005650, "name": "KALEO", "general_description": "Pharmaceutical development and manufacturing", "client_government_entity": false, "client_self_select": false, "state": "VA", "state_display": "Virginia", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2013-09-13"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Reducing opioid overdose deaths; implementation of HR 3680/S. 2256 provisions related to naloxone included in the conference report on S. 524, the Comprehensive Addiction and Recovery Act S.771 Improving Access to Affordable Prescription Drugs Act, S.469 Affordable and Safe Prescription Drug Importation Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43397, "prefix": "mr", "prefix_display": "MR.", "first_name": "MICHAEL", "nickname": null, "middle_name": "A", "last_name": "MEROLA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 45265, "prefix": null, "prefix_display": null, "first_name": "ROBERT", "nickname": null, "middle_name": null, "last_name": "ZUCKER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67707, "prefix": null, "prefix_display": null, "first_name": "CHARLA", "nickname": null, "middle_name": null, "last_name": "PENN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 59796, "prefix": null, "prefix_display": null, "first_name": "CHELSEY", "nickname": null, "middle_name": null, "last_name": "PENROD HICKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 60070, "prefix": null, "prefix_display": null, "first_name": "CARL", "nickname": null, "middle_name": null, "last_name": "CHIDLOW", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 23160, "prefix": null, "prefix_display": null, "first_name": "DONNA", "nickname": null, "middle_name": null, "last_name": "MULLINS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 65400, "prefix": null, "prefix_display": null, "first_name": "MOLLY", "nickname": null, "middle_name": null, "last_name": "MCDONNELL", "suffix": null, "suffix_display": null}, "covered_position": "LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance", "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 19, "name": "Office of Natl Drug Control Policy (NDCP)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Pharmaceutical drug development including epinephrine for anaphylaxis", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43397, "prefix": "mr", "prefix_display": "MR.", "first_name": "MICHAEL", "nickname": null, "middle_name": "A", "last_name": "MEROLA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 45265, "prefix": null, "prefix_display": null, "first_name": "ROBERT", "nickname": null, "middle_name": null, "last_name": "ZUCKER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67707, "prefix": null, "prefix_display": null, "first_name": "CHARLA", "nickname": null, "middle_name": null, "last_name": "PENN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 59796, "prefix": null, "prefix_display": null, "first_name": "CHELSEY", "nickname": null, "middle_name": null, "last_name": "PENROD HICKMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 60070, "prefix": null, "prefix_display": null, "first_name": "CARL", "nickname": null, "middle_name": null, "last_name": "CHIDLOW", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 23160, "prefix": null, "prefix_display": null, "first_name": "DONNA", "nickname": null, "middle_name": null, "last_name": "MULLINS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 65400, "prefix": null, "prefix_display": null, "first_name": "MOLLY", "nickname": null, "middle_name": null, "last_name": "MCDONNELL", "suffix": null, "suffix_display": null}, "covered_position": "LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance", "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 19, "name": "Office of Natl Drug Control Policy (NDCP)"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 34724 VA   US US Pharmaceutical development and manufacturing 0 0 1938056   alias 0.85

Links from other tables